Carbocisteine (INN), also called carbocysteine (USAN), is a mucolytic that reduces the viscosity of sputum and so can be used to help relieve the symptoms of chronic obstructive pulmonary disorder (COPD) and bronchiectasis by allowing the sufferer to bring up sputum more easily. Carbocisteine should not be used with antitussives (cough suppressants) or medicines that dry up bronchial secretions.
Carbocisteine (INN), also called carbocysteine (USAN), is a mucolytic that reduces the viscosity of sputum and so can be used to help relieve the symptoms of chronic obstructive pulmonary disorder (COPD) and bronchiectasis by allowing the sufferer to bring up sputum more easily. Carbocisteine should not be used with antitussives (cough suppressants) or medicines that dry up bronchial secretions.
In the last several years, Global market of Carbocisteine developed steady, with an average growth rate of 5.2%. In 2016, Global Revenue of Carbocisteine is nearly 35 M USD; the actual production is about 1600 MT.
The classification of Carbocisteine includes 98.5% and >98.5%, and the sales proportion of >98.5% in 2016 is about 76.2%.
Carbocisteine is widely used to make drugs, the formal of drugs include Oral Solution, Tablet & Capsule and Other. The most proportion of Carbocisteine formal is Tablet & Capsule and the proportion in 2016 is about 74%.
China is the largest supplier of Carbocisteine, with a revenue market share nearly 46% in 2016. India is the second largest supplier of Carbocisteine, enjoying revenue market share nearly 25% in 2016.
Europe is the largest consumption place, with a consumption market share nearly 33% in 2016. Following Europe, China is the second largest consumption place with the consumption market share of 26%.
Market competition is not intense. Wuhan Grand Hoyo, Moehs Iberica, Afton Pharma, etc. are the leaders of the industry, and they hold key technologies and patents, with high-end customers; have been formed in the monopoly position in the industry.
According to this study, over the next five years the Carbocisteine market will register a 4.3% CAGR in terms of revenue, the global market size will reach US$ 57 million by 2024, from US$ 44 million in 2019. In particular, this report presents the global market share (sales and revenue) of key companies in Carbocisteine business, shared in Chapter 3.
This report presents a comprehensive overview, market shares, and growth opportunities of Carbocisteine market by product type, application, key manufacturers and key regions and countries.
This study considers the Carbocisteine value and volume generated from the sales of the following segments:
Segmentation by product type: breakdown data from 2014 to 2019, in Section 2.3; and forecast to 2024 in section 11.7.
0.985
>98.5%
Segmentation by application: breakdown data from 2014 to 2019, in Section 2.4; and forecast to 2024 in section 11.8.
Oral Solution
Tablet & Capsule
Others
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Spain
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report: Breakdown data in in Chapter 3.
Wuhan Grand Hoyo
Moehs Iberica
Afton Pharma
Jinshi Pharm
Hengkang Pharma
Globe Quimica
Xiangyu Pharmaceutical
...
In addition, this report discusses the key drivers influencing market growth, opportunities, the challenges and the risks faced by key manufacturers and the market as a whole. It also analyzes key emerging trends and their impact on present and future development.
Research objectives
To study and analyze the global Carbocisteine consumption (value & volume) by key regions/countries, product type and application, history data from 2014 to 2018, and forecast to 2024.
To understand the structure of Carbocisteine market by identifying its various subsegments.
Focuses on the key global Carbocisteine manufacturers, to define, describe and analyze the sales volume, value, market share, market competition landscape, SWOT analysis and development plans in next few years.
To analyze the Carbocisteine with respect to individual growth trends, future prospects, and their contribution to the total market.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
To project the consumption of Carbocisteine submarkets, with respect to key regions (along with their respective key countries).
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
To strategically profile the key players and comprehensively analyze their growth strategies.
Summary:
Get latest Market Research Reports on Carbocisteine . Industry analysis & Market Report on Carbocisteine is a syndicated market report, published as Global Carbocisteine Market Growth 2019-2024. It is complete Research Study and Industry Analysis of Carbocisteine market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.